Advertisement
Screener

Nuo Therapeutics, Inc. (AURX) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend

2.8 / 5 stars · 68/120 Roast Me

Nuo Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend

Nuo Therapeutics, Inc. (AURX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend of $0 for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-14.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend · last filed 2014-08-14

  • Nuo Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average expected dividend for the quarter ending 2014-03-31 was $0.00.
  • Nuo Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average expected dividend for the quarter ending 2013-03-31 was $0.00.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend 6 month
2014-06-30$0.00
10-Q · filed 2014-08-14
2014-03-31$0.00
10-Q · filed 2014-05-15
2013-06-30$0.00
10-Q · filed 2014-08-14
2013-03-31$0.00
10-Q · filed 2014-05-15